Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2

Background: Patients with diabetes mellitus show a higher risk of developing depressive symptoms when compared to healthy people, hampering the management and prognosis of both diseases. However, national studies on the topic are scarce. Aim: To study the frequency and severity of depressive sympt...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Valenzuela,María José, Münzenmayer,Bárbara, Osorio,Tomás, Arancibia,Marcelo, Madrid,Eva
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2018
Materias:	Depression, Patient Compliance Diabetes Mellitus, Type 2 Primary Health Care Outpatients
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201415
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872018001201415
record_format	dspace
spelling	oai:scielo:S0034-988720180012014152019-02-18Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2Valenzuela,María JoséMünzenmayer,BárbaraOsorio,TomásArancibia,MarceloMadrid,Eva Depression, Patient Compliance Diabetes Mellitus, Type 2 Primary Health Care Outpatients Background: Patients with diabetes mellitus show a higher risk of developing depressive symptoms when compared to healthy people, hampering the management and prognosis of both diseases. However, national studies on the topic are scarce. Aim: To study the frequency and severity of depressive symptoms in patients with type 2 diabetes. Material and Methods: Beck Depression Inventory-IA and Morisky Green Levine scale were administered to diabetic patients under control at a primary care center. Pharmacological compliance was evaluated using glycosylated hemoglobin levels obtained from their clinical records. Results: We included 323 patients aged 64 ± 12 years (49% women). The frequency of depressive symptoms was 34.7%. Compared with their counterparts without depressive symptoms, patients with depression showed higher glycosylated hemoglobin levels (7.2 ± 1.7 and 6.7 ± 1.3% respectively), a higher frequency of non-compliance with treatment (63 and 43% respectively) and a higher frequency of metabolic decompensation (38 and 23% respectively). Depressive symptomatology was more common among women. Conclusions: Patients with type 2 diabetes mellitus and depressive symptoms exhibit a poorer treatment compliance and worse metabolic control as compared to their non-depressive counterparts.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.12 20182018-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201415es10.4067/s0034-98872018001201415
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Depression, Patient Compliance Diabetes Mellitus, Type 2 Primary Health Care Outpatients
spellingShingle	Depression, Patient Compliance Diabetes Mellitus, Type 2 Primary Health Care Outpatients Valenzuela,María José Münzenmayer,Bárbara Osorio,Tomás Arancibia,Marcelo Madrid,Eva Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
description	Background: Patients with diabetes mellitus show a higher risk of developing depressive symptoms when compared to healthy people, hampering the management and prognosis of both diseases. However, national studies on the topic are scarce. Aim: To study the frequency and severity of depressive symptoms in patients with type 2 diabetes. Material and Methods: Beck Depression Inventory-IA and Morisky Green Levine scale were administered to diabetic patients under control at a primary care center. Pharmacological compliance was evaluated using glycosylated hemoglobin levels obtained from their clinical records. Results: We included 323 patients aged 64 ± 12 years (49% women). The frequency of depressive symptoms was 34.7%. Compared with their counterparts without depressive symptoms, patients with depression showed higher glycosylated hemoglobin levels (7.2 ± 1.7 and 6.7 ± 1.3% respectively), a higher frequency of non-compliance with treatment (63 and 43% respectively) and a higher frequency of metabolic decompensation (38 and 23% respectively). Depressive symptomatology was more common among women. Conclusions: Patients with type 2 diabetes mellitus and depressive symptoms exhibit a poorer treatment compliance and worse metabolic control as compared to their non-depressive counterparts.
author	Valenzuela,María José Münzenmayer,Bárbara Osorio,Tomás Arancibia,Marcelo Madrid,Eva
author_facet	Valenzuela,María José Münzenmayer,Bárbara Osorio,Tomás Arancibia,Marcelo Madrid,Eva
author_sort	Valenzuela,María José
title	Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
title_short	Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
title_full	Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
title_fullStr	Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
title_full_unstemmed	Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
title_sort	sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2
publisher	Sociedad Médica de Santiago
publishDate	2018
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201415
work_keys_str_mv	AT valenzuelamariajose sintomatologiadepresivaycontrolmetabolicoenpacientesambulatoriosportadoresdediabetesmellitustipo2 AT munzenmayerbarbara sintomatologiadepresivaycontrolmetabolicoenpacientesambulatoriosportadoresdediabetesmellitustipo2 AT osoriotomas sintomatologiadepresivaycontrolmetabolicoenpacientesambulatoriosportadoresdediabetesmellitustipo2 AT arancibiamarcelo sintomatologiadepresivaycontrolmetabolicoenpacientesambulatoriosportadoresdediabetesmellitustipo2 AT madrideva sintomatologiadepresivaycontrolmetabolicoenpacientesambulatoriosportadoresdediabetesmellitustipo2
_version_	1718437037343768576

Sintomatologia depresiva y control metabólico en pacientes ambulatorios portadores de diabetes mellitus tipo 2

Ejemplares similares